W Paul Glezen

Summary

Affiliation: Baylor College of Medicine
Country: USA

Publications

  1. ncbi request reprint Commentary: benefits of influenza vaccine in US elderly--new studies raise questions
    W Paul Glezen
    Department of Molecular Virology and Microbiology, and Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA
    Int J Epidemiol 35:352-3. 2006
  2. ncbi request reprint Herd protection against influenza
    W Paul Glezen
    MVM Department, Baylor College of Medicine, One Baylor Plaza, MS BCM 280, Houston, TX 77030, United States
    J Clin Virol 37:237-43. 2006
  3. ncbi request reprint Asthma, influenza, and vaccination
    W Paul Glezen
    Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA
    J Allergy Clin Immunol 118:1199-206; quiz 1207-8. 2006
  4. doi request reprint Universal influenza vaccination and live attenuated influenza vaccination of children
    W Paul Glezen
    Department of MVM, Baylor College of Medicine, Houston, TX 77030, USA
    Pediatr Infect Dis J 27:S104-9. 2008
  5. pmc Direct and indirect effectiveness of influenza vaccination delivered to children at school preceding an epidemic caused by 3 new influenza virus variants
    W Paul Glezen
    Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas 77030, USA
    J Infect Dis 202:1626-33. 2010
  6. ncbi request reprint Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children
    Pedro A Piedra
    Baylor College of Medicine, Department of Molecular Virology and Microbiology, Room 248E, One Baylor Plaza, Houston, TX 77030, USA
    Pediatrics 120:e553-64. 2007
  7. ncbi request reprint Improving influenza immunization in pregnant women and healthcare workers
    Melanie E Mouzoon
    Kelsey Seybold Clinic, Houston, TX, USA
    Am J Manag Care 16:209-16. 2010
  8. pmc Live attenuated influenza vaccine, trivalent, is safe in healthy children 18 months to 4 years, 5 to 9 years, and 10 to 18 years of age in a community-based, nonrandomized, open-label trial
    Pedro A Piedra
    Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas 77030, USA
    Pediatrics 116:e397-407. 2005
  9. pmc Picornavirus, the most common respiratory virus causing infection among patients of all ages hospitalized with acute respiratory illness
    Robert L Atmar
    Viral Respiratory Pathogens Research Unit and the Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA
    J Clin Microbiol 50:506-8. 2012
  10. ncbi request reprint Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children
    Pedro A Piedra
    Department of Molecular Virology and Microbiology, Baylor College of Medicine, Rm 248E, One Baylor Plaza, Houston, TX 77030, USA
    Vaccine 23:1540-8. 2005

Collaborators

Detail Information

Publications30

  1. ncbi request reprint Commentary: benefits of influenza vaccine in US elderly--new studies raise questions
    W Paul Glezen
    Department of Molecular Virology and Microbiology, and Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA
    Int J Epidemiol 35:352-3. 2006
  2. ncbi request reprint Herd protection against influenza
    W Paul Glezen
    MVM Department, Baylor College of Medicine, One Baylor Plaza, MS BCM 280, Houston, TX 77030, United States
    J Clin Virol 37:237-43. 2006
    ..School-based clinics could provide a platform for rapid deployment of vaccine accessible to all segments of the population. This strategy could be critical for control of pandemic influenza...
  3. ncbi request reprint Asthma, influenza, and vaccination
    W Paul Glezen
    Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA
    J Allergy Clin Immunol 118:1199-206; quiz 1207-8. 2006
    ..Universal vaccination of all children in school-based clinics will facilitate control of epidemic influenza and provide an infrastructure for control of future influenza pandemics...
  4. doi request reprint Universal influenza vaccination and live attenuated influenza vaccination of children
    W Paul Glezen
    Department of MVM, Baylor College of Medicine, Houston, TX 77030, USA
    Pediatr Infect Dis J 27:S104-9. 2008
    ..Systematic delivery of influenza vaccine in school-based and workplace-based clinics would greatly enhance the control of epidemic influenza and help prepare for the next pandemic...
  5. pmc Direct and indirect effectiveness of influenza vaccination delivered to children at school preceding an epidemic caused by 3 new influenza virus variants
    W Paul Glezen
    Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas 77030, USA
    J Infect Dis 202:1626-33. 2010
    ..This field trial examines the effectiveness of school-based clinics for vaccine delivery before an epidemic caused by 3 new influenza virus variants not contained in the vaccine...
  6. ncbi request reprint Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children
    Pedro A Piedra
    Baylor College of Medicine, Department of Molecular Virology and Microbiology, Room 248E, One Baylor Plaza, Houston, TX 77030, USA
    Pediatrics 120:e553-64. 2007
    ..The objective of this study was to determine the effectiveness of influenza vaccines for healthy school-aged children when administered during the influenza outbreak...
  7. ncbi request reprint Improving influenza immunization in pregnant women and healthcare workers
    Melanie E Mouzoon
    Kelsey Seybold Clinic, Houston, TX, USA
    Am J Manag Care 16:209-16. 2010
    ..To evaluate the effect of several strategies to increase influenza immunization in a multispecialty clinic...
  8. pmc Live attenuated influenza vaccine, trivalent, is safe in healthy children 18 months to 4 years, 5 to 9 years, and 10 to 18 years of age in a community-based, nonrandomized, open-label trial
    Pedro A Piedra
    Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas 77030, USA
    Pediatrics 116:e397-407. 2005
    ....
  9. pmc Picornavirus, the most common respiratory virus causing infection among patients of all ages hospitalized with acute respiratory illness
    Robert L Atmar
    Viral Respiratory Pathogens Research Unit and the Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA
    J Clin Microbiol 50:506-8. 2012
    ..The molecular assays doubled the number of infections identified; picornaviruses were the most frequent in patients of all ages, followed by respiratory syncytial virus and influenza viruses...
  10. ncbi request reprint Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children
    Pedro A Piedra
    Department of Molecular Virology and Microbiology, Baylor College of Medicine, Rm 248E, One Baylor Plaza, Houston, TX 77030, USA
    Vaccine 23:1540-8. 2005
    ..Vaccination of approximately 20-25% of children, 1.5-18 years of age in the intervention communities resulted in an indirect protection of 8-18% against MAARI in adults > or =35 years of age...
  11. ncbi request reprint Medically attended pediatric influenza during the resurgence of the Victoria lineage of influenza B virus
    Ladonna K Hite
    Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA
    Int J Infect Dis 11:40-7. 2007
    ..During the 2002-2003 season, a new variant of influenza B co-circulated with influenza A viruses. This study examines the characteristics and outcomes of children with influenza A and B virus infection vs. other acute respiratory illnesses...
  12. ncbi request reprint The changing epidemiology of respiratory syncytial virus and influenza: impetus for new control measures
    W Paul Glezen
    Departments of Molecular Virology and Microbiology and of Pediatrics, Baylor College of Medicine, Houston, TX, USA
    Pediatr Infect Dis J 23:S202-6. 2004
    ..Medical encounters for acute respiratory illness peak each winter, coinciding with the peak of influenza activity. RSV is the most important cause of hospitalization of infants for acute lower respiratory illness...
  13. pmc Control of influenza
    W Paul Glezen
    Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas 77030 3498, USA
    Tex Heart Inst J 31:39-41. 2004
    ..The availability of the live, attenuated, cold-adapted nasal spray vaccine should facilitate this goal...
  14. ncbi request reprint Cold-adapted, live attenuated influenza vaccine
    W Paul Glezen
    Department of Molecular Virology and Microbiology, Baylor College of Medicine, One Baylor Plaza, Mail Stop BCM 280, Houston, TX 77030 3498, USA
    Expert Rev Vaccines 3:131-9. 2004
    ..Use of CAIV-T in children will not only decrease the risk of serious disease, but also dampen the spread of the virus in the community and reduce exposure of patients who are at high risk of complications and death...
  15. ncbi request reprint Respiratory viral infections in patients with chronic, obstructive pulmonary disease
    J David Beckham
    Department of Medicine, Baylor College of Medicine and Ben Taub General Hospital, One Baylor Plaza, Houston, TX 77030, USA
    J Infect 50:322-30. 2005
    ..The purpose of the present study was to apply reverse transcription-PCR (RT-PCR) assays to clinical specimens collected from patients with acute respiratory illness and chronic obstructive pulmonary disease (COPD)...
  16. ncbi request reprint Safety of influenza vaccination during pregnancy
    Flor M Munoz
    Baylor College of Medicine, Department of Pediatrics and Molecular Virology, Houston, TX 77030, USA
    Am J Obstet Gynecol 192:1098-106. 2005
    ..The purpose of this study was to evaluate the safety of influenza vaccine that is administered in the second or third trimester of gestation...
  17. ncbi request reprint New vaccines for old diseases: trivalent cold-adapted influenza vaccine
    W Paul Glezen
    Department of Molecular Virology and Microbiology, and Pediatrics, Baylor College of Medicine, Houston, TX 77030 3498, USA
    Pediatr Ann 33:545-50. 2004
    ..The number of excess deaths is expected to double within the next 25 years if control methods are not intensified. CAIV-T may become an important adjunct to control measures and can facilitate influenza pandemic preparedness...
  18. ncbi request reprint Correlates of immunity to respiratory syncytial virus (RSV) associated-hospitalization: establishment of minimum protective threshold levels of serum neutralizing antibodies
    Pedro A Piedra
    Department of Molecular Virology and Microbiology, Baylor College of Medicine, Rm 248E, One Baylor Plaza, Houston, TX, USA
    Vaccine 21:3479-82. 2003
    ..To determine if respiratory syncytial virus (RSV) specific, serum antibody titers correlate with protection against RSV associated-hospitalization at all ages...
  19. ncbi request reprint Session IV. Ethical, liability and regulatory issues
    W Paul Glezen
    Molecular Virology, Microbiology and Pediatric Influenza Research Center, Baylor College of Medicine, One Baylor Plaza Suite 221 D, Houston, TX 77030, USA
    Vaccine 21:3501-2. 2003
  20. ncbi request reprint Influenza vaccination for healthy children
    W Paul Glezen
    Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas 77030 3498, USA
    Curr Opin Infect Dis 15:283-7. 2002
    ..The new live attenuated nasal spray influenza vaccine is particularly effective in healthy children who would benefit most from universal immunization...
  21. ncbi request reprint Effect of maternal antibodies on the infant immune response
    W Paul Glezen
    Department of Molecular Virology and Microbiology, Baylor College of Medicine, One Baylor Plaza, Mail Stop BCM 280, Houston, TX 77030, USA
    Vaccine 21:3389-92. 2003
    ..No evidence for the development of fetal tolerance after immunization during pregnancy has occurred subsequently in infants following active vaccination...
  22. doi request reprint Safety of the intranasal, trivalent, live attenuated influenza vaccine (LAIV) in children with intermittent wheezing in an open-label field trial
    Manjusha J Gaglani
    Section of Pediatric Infectious Diseases, Department of Pediatrics, Scott and White Memorial Hospital and Clinic, Texas A and M University Health Science Center College of Medicine, Temple, TX 76508, USA
    Pediatr Infect Dis J 27:444-52. 2008
    ..Safety of the intranasal, trivalent, live attenuated influenza vaccine (LAIV) in children with asthma is unknown. A previous report showed an "asthma signal" in children aged 18-35 months...
  23. pmc Efficacy of trivalent, cold-adapted, influenza virus vaccine against influenza A (Fujian), a drift variant, during 2003-2004
    M Elizabeth Halloran
    Program in Biostatistics and Biomathematics, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
    Vaccine 25:4038-45. 2007
    ..LAIV-T was cross-protective with a drift variant strain in 2003-2004, evidence that such vaccines could be important for preparing for a pandemic and for annual influenza...
  24. ncbi request reprint Influenza control
    W Paul Glezen
    N Engl J Med 355:79-81. 2006
  25. ncbi request reprint Direct and total effectiveness of the intranasal, live-attenuated, trivalent cold-adapted influenza virus vaccine against the 2000-2001 influenza A(H1N1) and B epidemic in healthy children
    Manjusha J Gaglani
    Section of Pediatric Infectious Diseases, Department of Pediatrics, Scott and White Memorial Hospital and Clinic, The Texas A and M University System Health Science Center College of Medicine, Temple, 76508, USA
    Arch Pediatr Adolesc Med 158:65-73. 2004
    ....
  26. ncbi request reprint A personnel time-motion study of intranasal influenza vaccination in healthy children
    Michael L Washington
    Health Services Research and Evaluation Branch, Immunization Services Division, MS E52, Atlanta, GA 30329, USA
    Vaccine 23:4879-85. 2005
    ..Total family visit time decreased by 64 s if the youngest child was receiving a second dose. Alternative delivery systems (e.g., group visits) are needed to take advantage of short vaccination times...
  27. ncbi request reprint Estimating efficacy of trivalent, cold-adapted, influenza virus vaccine (CAIV-T) against influenza A (H1N1) and B using surveillance cultures
    M Elizabeth Halloran
    Department of Biostatistics, Rollins School of Public Health, Emory University, 1518 Clifton Road NE, Atlanta, GA 30322, USA
    Am J Epidemiol 158:305-11. 2003
    ..CAIV-T provides substantial protection against a mixture of influenza A (H1N1) and B. Results demonstrate the powerful potential of using validation sets for outcomes in vaccine field studies...
  28. ncbi request reprint Safety of cold-adapted live influenza vaccine
    W Paul Glezen
    Pediatr Infect Dis J 23:593-4; author reply 594. 2004
  29. ncbi request reprint Estimating deaths due to influenza and respiratory syncytial virus
    W Paul Glezen
    JAMA 289:2500; author reply 2500-2. 2003
  30. ncbi request reprint Immunogenic protein contaminants in pneumococcal vaccines
    Jigui Yu
    Department of Pathology, University of Alabama at Birmingham, Birmingham, AL 35294, USA
    J Infect Dis 187:1019-23. 2003
    ..The degree of contamination was highly variable, and this should be considered in pneumococcal vaccine evaluations or when capsular polysaccharide is used for pneumococcal antibody assays...